Evidence map›Paper›PMID 22323600›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Forkhead box N4 (Foxn4) activates Dll4-Notch signaling to suppress photoreceptor cell fates of early retinal progenitors.

Huijun Luo, Kangxin Jin, Zhenhui Xie, Feng Qiu, Shengguo Li, Min Zou, Li Cai, Katsuto Hozumi, David T Shima, Mengqing Xiang

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Foxn3 is required to suppress aberrant ciliogenesis in nonphotoreceptor retinal neurons.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. A framework to identify functional interactors that contribute to disrupted early retinal development in Vsx2 ocular retardation J mice.Developmental dynamics : an official publication of the American Association of Anatomists · 2023
    Article
  7. Article
  8. Article
  9. miScience · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Genetic control of retinal ganglion cell genesis.Cellular and molecular life sciences : CMLS · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Huijun LuoCenter for Advanced Biotechnology and Medicine and Department of Pediatrics, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
Kangxin Jin
Zhenhui Xie
Feng Qiu
Shengguo Li
Min Zou
Li Cai
Katsuto Hozumi
David T Shima
Mengqing Xiang
Johnson University · USRutgers, The State University of New Jersey · USTokai University · JPUniversity College London · GB

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Chang S Chan · 1997 to 2026
$94.5M
Transcriptional Regulation of Retinal DevelopmentR01EY012020 · NEI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI XIANG, MENGQING · 1998 to 2012
$3.7M
Dll4 Gene Regulation and Function during RetinogenesisR01EY020849 · NEI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI XIANG, MENGQING · 2010 to 2013
$1.5M
Comparative genomic and molecular genetics approaches to retinal stem cellsR21EY018738 · NEI · RUTGERS, THE STATE UNIV OF N.J. · PI CAI, LI · 2008 to 2009
$412k
NCI NIH HHS P30 CA072720NEI NIH HHS EY012020NEI NIH HHS EY018738NEI NIH HHS EY020849NEI NIH HHS R01 EY012020NEI NIH HHS R01 EY020849NEI NIH HHS R21 EY018738
6 · The paper itself

Abstract

The generation of diverse neuronal types and subtypes from multipotent progenitors during development is crucial for assembling functional neural circuits in the adult central nervous system. During mouse retinogenesis, early retinal progenitors give rise to several cell types, including ganglion, amacrine, horizontal, cone, and rod cells. It is unknown at present how each of these fates is selected from the multiple neuronal fates available to the early progenitor. By using a combination of bioinformatic, genetic, and biochemical approaches, we investigated the mechanism by which Foxn4 selects the amacrine and horizontal cell fates from multipotential retinal progenitors. These studies indicate that Foxn4 has an intrinsic activity to suppress the alternative photoreceptor cell fates of early retinal progenitors by selectively activating Dll4-Notch signaling. Gene expression and conditional ablation analyses reveal that Dll4 is directly activated by Foxn4 via phylogenetically conserved enhancers and that Dll4 can partly mediate the Foxn4 function by serving as a major Notch ligand to expand the progenitor pool and limit photoreceptor production. Our data together define a Foxn4-mediated molecular and signaling pathway that underlies the suppression of alternative cell fates of early retinal progenitors.

Indexed as

Adaptor Proteins, Signal TransducingAmacrine CellsAnimalsCalcium-Binding ProteinsCell DifferentiationCell LineageConserved SequenceEnhancer Elements, GeneticEye ProteinsForkhead Transcription FactorsGene Expression ProfilingGene Expression Regulation, DevelopmentalGenes, ReporterIntracellular Signaling Peptides and ProteinsMembrane ProteinsMiceAdaptor Proteins, Signal TransducingCalcium-Binding ProteinsDLL4 protein, mouseEye ProteinsForkhead Transcription FactorsFoxn4 protein, mouseIntracellular Signaling Peptides and ProteinsMembrane ProteinsReceptors, NotchRecombinant Fusion Proteins

Identifiers

PMID22323600
PMCPMC3295323
OpenAlexW2158314538

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.